Engineering Chimeric Antigen Receptor T Cells for Solid Tumour Therapy

Scientists discuss tumor microenvironment-associated aspects with an emphasis on T cell trafficking, extracellular matrix barriers, abnormal vasculature, solid tumor heterogenicity, and immune suppressive microenvironment.